We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DS
1876
DELISTED
Drive Shack Inc.
DS
$225K ﹤0.01%
29,184
+20,448
+234% +$123K
EQBK icon
1877
Equity Bancshares
EQBK
$1.06B
$224K ﹤0.01%
5,404
HVT icon
1878
Haverty Furniture Companies
HVT
$443M
$224K ﹤0.01%
10,391
OMN
1879
DELISTED
OMNOVA Solutions Inc.
OMN
$224K ﹤0.01%
21,500
+8,349
+63% +$89K
KDNY
1880
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$223K ﹤0.01%
6,360
+2,631
+71% +$101K
BHB icon
1881
Bar Harbor Bankshares
BHB
$667M
$222K ﹤0.01%
7,342
CRMT icon
1882
America's Car Mart
CRMT
$26.8M
$222K ﹤0.01%
3,580
UPL
1883
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$222K ﹤0.01%
96,029
TRC icon
1884
Tejon Ranch
TRC
$447M
$221K ﹤0.01%
9,079
UTMD icon
1885
Utah Medical Products
UTMD
$229M
$221K ﹤0.01%
2,002
TVRD
1886
Tvardi Therapeutics
TVRD
$22.1M
$220K ﹤0.01%
319
FRPH icon
1887
FRP Holdings
FRPH
$425M
$219K ﹤0.01%
6,778
FBMS
1888
DELISTED
The First Bancshares, Inc.
FBMS
$219K ﹤0.01%
6,100
+1,646
+37% +$55.5K
PLUG icon
1889
Plug Power
PLUG
$3.1B
$218K ﹤0.01%
107,957
CASI
1890
DELISTED
CASI Pharmaceuticals
CASI
$217K ﹤0.01%
+2,632
New +$178K
IMMR icon
1891
Immersion
IMMR
$248M
$217K ﹤0.01%
14,029
MODN
1892
DELISTED
MODEL N, INC.
MODN
$215K ﹤0.01%
11,583
AKBA icon
1893
Akebia Therapeutics
AKBA
$240M
$214K ﹤0.01%
21,429
FMNB icon
1894
Farmers National Banc Corp
FMNB
$952M
$214K ﹤0.01%
13,414
TPIC
1895
DELISTED
TPI Composites
TPIC
$214K ﹤0.01%
+7,332
New +$185K
FISI icon
1896
Financial Institutions
FISI
$821M
$213K ﹤0.01%
6,461
JOUT icon
1897
Johnson Outdoors
JOUT
$494M
$213K ﹤0.01%
2,524
YORW icon
1898
York Water
YORW
$527M
$213K ﹤0.01%
6,695
ASRT
1899
DELISTED
Assertio
ASRT
$209K ﹤0.01%
523
LFCR icon
1900
Lifecore Biomedical
LFCR
$183M
$209K ﹤0.01%
14,010

Similar funds

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.